Zimmer Biomet Holdings (ZBH) Tops Q4 EPS by 1c, guides below consensus

Zimmer Biomet Holdings (NYSE: ZBH) reported Q4 EPS of $2.31, $0.01 better than the analyst estimate of $2.30. Revenue for the quarter came in at $2.02 billion versus the consensus estimate of $2.01 billion.

GUIDANCE:

Zimmer Biomet Holdings sees FY2025 EPS of $8.15-$8.35, versus the consensus of $8.55.

For earnings history and earnings-related data on Zimmer Biomet Holdings (ZBH) click here.

You May Also Be Interested In

• GameStop CEO Cohen buys 1.15M shares
• GM Defense wins $697.7 million Army contract modification
• Lilly breaks ground on $6.5B Houston drug manufacturing site